Patent Assignment
Reel/Frame 035034/0539
Release of Security Interest
Recorded: 2015-02-18
Pages: 9
Assignor
GE BUSINESS CAPITAL CORPORATION FORMERLY TRANSAMERICA BUSINESS CAPITAL CORPORATION
Executed: 2010-12-02
Assignee
DENDREON CORPORATION
1301 2ND AVENUE, SEATTLE, WASHINGTON, 98101
Covered Properties
(16)
Idiotypic Vaccination Against B Cell Lymphoma
Application:
07/493,511 →
Publication:
US 2003/0072751
Suppressor and Progenitor Cells
Patent:
5,985,656 →
Application:
07/971,723 →
Potent Antigen Presenting Cell Composition
Patent:
6,121,044 →
Application:
08/501,987 →
Methods for in Vivo T Cell Activation by Antigen-Pulsed Dendritic Cells
Application:
08/575,432 →
Immunostimulatory Composition and Method
Patent:
6,080,409 →
Application:
08/579,823 →
Methods for Using Dendritic Cells to Activate Gamma/Delta-T Cell Receptor-Positive T Cells
Patent:
6,821,778 →
Application:
08/610,195 →
Growth Arrest Gene Compositions and Methods
Patent:
5,998,599 →
Application:
08/883,070 →
Process for Making Silanized Colloidal Silica
Patent:
6,015,843 →
Application:
09/006,775 →
Prostate Tumor Polynucleotide Compositions and Methods of Detection Thereof
Patent:
6,194,152 →
Application:
09/112,096 →
Cell Washing Device and Method
Patent:
6,197,579 →
Application:
09/118,326 →
Immunostimulatory Compositions
Patent:
5,976,546 →
Application:
09/146,283 →
Immunostimulatory Composition
Patent:
6,210,662 →
Application:
09/344,195 →
Compositions and Methods for Enhancement of Major Histocompatibility Complex Class I Restricted Antigen Presentation
Patent:
7,148,324 →
Application:
09/461,684 →
Selective Apoptosis of Neoplastic Cells by an Hla-Dr Specific Monoclonial Antibody
Application:
60/098,292 →
Dendritic Cell Isolated from Human Peripheral Blood Mononuclear Cells
Application:
60/158,618 →
Cryopreservation of Antigen-Loaded Dendritic Cells and Their Precursors in Serum-Free Media
Application:
60/168,991 →
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 16, 2015
From: DENDREON CORPORATION, AND ITS WHOLLY OWNED SUBSIDIARIES, DENDREON HOLDINGS, LLC, DENDREON DISTRIBUTION, LLC, AND DENDREON MANUFACTORING, LLC
To: DRONE ACQUISITION SUB INC.
Reel/Frame 036126/0259 →
Change of Name
Jul 20, 2015
From: DRONE ACQUISITION SUB INC.
To: DENDREON PHARMACEUTICALS, INC.
Reel/Frame 036136/0181 →
Court Order
Jul 22, 2015
From: TRANSAMERICA BUSINESS CREDIT CORPORATION
To: DENDREON CORPORATION
Reel/Frame 036159/0256 →
Security Agreement
Jul 27, 2015
From: DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036190/0503 →
Change of Name
May 3, 2017
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 042389/0505 →
Release of Security Interest
Jul 5, 2017
From: BARCLAYS BANK PLC
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 043089/0288 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042389 Frame: 505. Assignor(S) Hereby Confirms the Change of Name.
Feb 14, 2018
From: DENDREON PHARMACEUTICALS, INC.
To: DENDREON PHARMACEUTICALS LLC
Reel/Frame 046088/0882 →